Flu News and Research

RSS

Flu and COVID-19 report offers latest surveillance data and public health advice

This fortnightly flu and COVID-19 report brings together the latest surveillance data along with the latest public health advice.

21 Jul 2023

Pertussis vaccination responses in COPD patients

Researchers evaluated the humoral and cellular immune responses to pertussis vaccination in COPD patients.

21 Jul 2023

How the COVID-19 pandemic altered antibiotic prescribing for common bacterial infections

Investigators evaluated the impact of the coronavirus disease 2019 pandemic on the use of antibiotics in primary care for common infections.

20 Jul 2023

Neighborhood environment can increase risk of COVID-19 hospitalization, study reveals

The range of COVID-19 symptoms varies-;some feel a mild cold, others are hospitalized, while others perish. Many studies have linked the severity of COVID-19 symptoms with an individual's biological factors, but less is known about the impact of non-biological factors, such as the environment in which people live.

14 Jul 2023

Novel vaccine against Lyme disease reported to be safe and effective

Researchers determine the safety and immunogenicity of a novel candidate vaccine against Lyme borreliosis.

11 Jul 2023

FOUR PAWS highlights World Zoonoses Day 2023 and outbreak of Highly Pathogenic Avian Influenza

Today, on World Zoonosis Day, global animal welfare organisation FOUR PAWS flags that governments have not learnt the lesson from COVID-19 that human, environmental and animal health must be addressed together to prevent another pandemic.

10 Jul 2023

The vital role of smartphone apps during the COVID-19 pandemic

At the start of the coronavirus disease 2019 (COVID-19) pandemic, analog techniques like nasopharyngeal swab specimens for polymerase chain reaction (PCR) testing were prominent. The widespread use of nonpharmaceutical interventions (NPIs) such as facemasks and social distancing was reminiscent of the influenza outbreak in 1918.

9 Jul 2023

New vaccine protects infant monkeys from diarrhea and promotes growth

A vaccine originally developed to prevent bacteria-caused diarrhea has now also been found to help infant nonhuman primates grow faster, according to a new study published in Nature Communications.

6 Jul 2023

AI predicts on- and off-target activity of RNA-targeting CRISPRs

Artificial intelligence can predict on- and off-target activity of CRISPR tools that target RNA instead of DNA, according to new research published in Nature Biotechnology.

3 Jul 2023

Advances in influenza research

This interview with Dr. Mohammad S Safiarian, Associate Product Manager at Sino Biological, discusses the advances in influenza research and how effective vaccines are developed.

From Sino Biological Inc. 30 Jun 2023

New sensor chip detects disease pathogens with 10x sensitivity

Texas A&M AgriLife Research scientists and collaborators at Iowa State University have developed a sensor chip that can detect many disease pathogens with 10 times the sensitivity of currently available methods.

26 Jun 2023

Key viral protein produced by influenza A can shred a host cell's genetic materials, finds study

Influenza A is one of two influenza viruses that fuel costly annual flu seasons and is a near constant threat to humans and many other animals. It's also responsible for occasional pandemics that, like the one in 1918, leave millions dead and wreak havoc on health systems and wider society.

23 Jun 2023

Plant based compound peruvoside may be able to prevent up to 12 medically important viruses

Peruvoside, a plant-based compound that is commonly used to treat heart failure, has been discovered to be able to prevent up to 12 medically important viruses, all originating from different virus families.

22 Jun 2023

Phase I clinical study of TCR NK cell therapy for sarcoma expected to commence later this year

The University of Texas MD Anderson Cancer Center and Replay today announced that the Food & Drug Administration (FDA) has issued a 'safe to proceed' for the Investigational New Drug (IND) application for NY-ESO-1 TCR/IL-15 NK, an engineered T cell receptor natural killer (TCR NK) cell therapy for advanced synovial sarcoma and myxoid/round cell liposarcoma.

20 Jun 2023

Exploring how Bourbon virus-carrying ticks travel through wildlife and to people

On a cold spring morning, Washington University in St. Louis virologist Jacco Boon, PhD, and wildlife ecologist Solny Adalsteinsson, PhD, flap and drag a large white flag through a woodsy area on the western edge of St. Louis County. Boon, an associate professor of medicine in infectious diseases at Washington University School of Medicine in St. Louis, and Adalsteinsson, a senior scientist at the university's Tyson Research Center, are looking for lone star ticks that carry the potentially deadly Bourbon virus.

14 Jun 2023

Immune resilience promotes longevity and resistance to infections

Researchers from The University of Texas Health Science Center at San Antonio, working with collaborators in five countries, today revealed that the capacity to resist or recover from infections and other sources of inflammatory stress -; called "immune resilience" -; differs widely among individuals.

13 Jun 2023

Vaccine against deadly chytrid fungus shifts microbiome to make frogs more resilient to future exposure

A human or animal's microbiome -; the collection of often beneficial microorganisms, including as bacteria and fungi, that live on or within a host organism -; can play an important role in the host's overall immune response, but it is unclear how vaccines against harmful pathogens impact the microbiome.

11 Jun 2023